✦ LIBER ✦

23LBA BEAM: A randomized phase II study evaluating the activity of BEvacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated Advanced Melanoma

✍ Scribed by S.J. O'Day; K.B. Kim; J.A. Sosman; A.C. Peterson; S. Feng; D.R. Minor; J.P. Fruehauf; G.P. Linette; S.N. Markovic; W.E. Carson

Book ID: 119600800
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)72058-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of sequential carboplat

A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer

✍ Guppy, A E; Nelstrop, A E; Foster, T; Agarwal, R; Seckl, M J; Rustin, G J S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

A phase II study of weekly paclitaxel an

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

✍ Andre Michel Kallab; Yasolatha Nalamolu; Paul Maclyn Dainer; Anand Prasad Jillel 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 73 KB

Randomized phase II study of weekly doce

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

✍ Lee M. Krug; Vincent A. Miller; Jyoti Patel; John Crapanzano; Christopher G. Azz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Treatment Rationale and Study Design for

Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer

✍ Bendell, Johanna C.; Ervin, Thomas J.; Gallinson, David; Singh, Jaswinder; Walla 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 608 KB

A Phase II, randomized, double-blind stu

A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)

✍ Cognetti, F.; Bagnato, A.; Colombo, N.; Savarese, A.; Scambia, G.; Sehouli, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Randomized phase II feasibility study of

Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer

✍ DOUILLARD, J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 103 KB